WO1990006116A3 - Medicaments pour le traitement de maladies inflammatoires chroniques des intestins - Google Patents

Medicaments pour le traitement de maladies inflammatoires chroniques des intestins Download PDF

Info

Publication number
WO1990006116A3
WO1990006116A3 PCT/EP1989/001426 EP8901426W WO9006116A3 WO 1990006116 A3 WO1990006116 A3 WO 1990006116A3 EP 8901426 W EP8901426 W EP 8901426W WO 9006116 A3 WO9006116 A3 WO 9006116A3
Authority
WO
WIPO (PCT)
Prior art keywords
intestines
inflammatory diseases
chronic inflammatory
agents
treating chronic
Prior art date
Application number
PCT/EP1989/001426
Other languages
German (de)
English (en)
Other versions
WO1990006116A2 (fr
Inventor
Ekkehard Scheiffele
Gerhard Gerber
Werner Siems
Andreas Werner
Original Assignee
Henning Berlin Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henning Berlin Gmbh filed Critical Henning Berlin Gmbh
Priority to DE8989912949T priority Critical patent/DE58903550D1/de
Priority to AT89912949T priority patent/ATE85522T1/de
Publication of WO1990006116A2 publication Critical patent/WO1990006116A2/fr
Publication of WO1990006116A3 publication Critical patent/WO1990006116A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

On peut traiter des maladies inflammatoires chroniques des intestins par administration entérique de doses pharmacologiquement efficaces d'oxypurinol et/ou de ses sels alcalins, alcalino-terreux ou ammoniacaux.
PCT/EP1989/001426 1988-11-25 1989-11-24 Medicaments pour le traitement de maladies inflammatoires chroniques des intestins WO1990006116A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE8989912949T DE58903550D1 (de) 1988-11-25 1989-11-24 Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen.
AT89912949T ATE85522T1 (de) 1988-11-25 1989-11-24 Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3839839.7 1988-11-25
DE3839839A DE3839839A1 (de) 1988-11-25 1988-11-25 Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen

Publications (2)

Publication Number Publication Date
WO1990006116A2 WO1990006116A2 (fr) 1990-06-14
WO1990006116A3 true WO1990006116A3 (fr) 1990-08-23

Family

ID=6367891

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1989/001426 WO1990006116A2 (fr) 1988-11-25 1989-11-24 Medicaments pour le traitement de maladies inflammatoires chroniques des intestins

Country Status (5)

Country Link
EP (1) EP0445156B1 (fr)
JP (1) JP2686566B2 (fr)
DE (2) DE3839839A1 (fr)
ES (1) ES2054097T3 (fr)
WO (1) WO1990006116A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102315D0 (sv) 2001-06-28 2001-06-28 Astrazeneca Ab Compounds
SE0203825D0 (sv) * 2002-12-20 2002-12-20 Astrazeneca Ab Novel fused heterocycles and uses thereof
WO2006083687A1 (fr) * 2005-01-28 2006-08-10 Cardiome Pharma Corp. Sel cristallin d'inhibiteurs de xanthine oxydase

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
AT352686B (de) * 1976-03-23 1979-10-10 Spiegl Paul Dr Verfahren zur herstellung von mikrokapseln
EP0062000A2 (fr) * 1981-03-18 1982-10-06 Stafford-Miller Continental Utilisation de l'acide amino-4 salicylique comme agent anti-inflammatoire
EP0261439A2 (fr) * 1986-08-28 1988-03-30 Mect Corporation Médicament pour soigner l'artériosclérose, contenant un dérivé de la pyrimido(2,1-b) benzothiazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA871813B (en) * 1986-03-13 1988-10-26 Wellcome Found Cell protection

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
AT352686B (de) * 1976-03-23 1979-10-10 Spiegl Paul Dr Verfahren zur herstellung von mikrokapseln
EP0062000A2 (fr) * 1981-03-18 1982-10-06 Stafford-Miller Continental Utilisation de l'acide amino-4 salicylique comme agent anti-inflammatoire
EP0261439A2 (fr) * 1986-08-28 1988-03-30 Mect Corporation Médicament pour soigner l'artériosclérose, contenant un dérivé de la pyrimido(2,1-b) benzothiazole

Also Published As

Publication number Publication date
DE58903550D1 (de) 1993-03-25
DE3839839A1 (de) 1990-05-31
EP0445156B1 (fr) 1993-02-10
WO1990006116A2 (fr) 1990-06-14
JP2686566B2 (ja) 1997-12-08
ES2054097T3 (es) 1994-08-01
JPH04502005A (ja) 1992-04-09
EP0445156A1 (fr) 1991-09-11
DE3839839C2 (fr) 1991-12-19

Similar Documents

Publication Publication Date Title
EP0379806A3 (fr) Pyrimidines et leurs sels acceptables en pharmacie, et leur utilisation comme médicaments
TW234691B (fr)
AU629777B2 (en) Blocking agents of edrf effect or formation for the treatment of shock
CA2125662A1 (fr) Systeme a administration transdermique contenant de l'acide acetylsalicylique pour le traitement de la thrombose et la prophylaxie du cancer
IE821214L (en) Medicament
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
IL90551A0 (en) Stable,injectable,aqueous pharmaceutical compositions for the treatment of cardiac conditions
NO894585L (no) Fremgangsmaate for fremstilling av polyeter-polyoler med redusert umetting.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
WO1990006116A3 (fr) Medicaments pour le traitement de maladies inflammatoires chroniques des intestins
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
AU8447991A (en) Antineoplastic effect potentiator and antineoplastic agent
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
FI901876A0 (fi) Ofullstaendiga hepadnavirus, vaccin producerande cellinjer samt terapi av leversjukdomar.
HRP970171A2 (en) Use of bradykinin antagonists for the preparation of medicaments to treat chronic fibrogenetic liver disease and acute liver disease
WO1986006960A3 (fr) Utilisation de nicorandile ou de pinacidile dans le traitement de maladies vasculaires peripheriques
NO890607D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
JPS55113721A (en) Immunity regulator
EP0260790A3 (fr) Utilisation de la pinacidile dans le traitement de l'incontinence
GB9323404D0 (en) Pharmaceuticals
EP0400312A3 (fr) Procédé et composition pour le traitement d'infections protozoiques avec un agent antibactérien
EP0419354A3 (en) Use of a complex of inosine with a n,n-dialkylamino-alkanol or one of its salts with a pharmacologically acceptable acid for the treatment of certain helmintic infections
NO891045L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater.
CA2099667A1 (fr) Agent pour le traitement des hepatopathies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE ES FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989912949

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989912949

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1989912949

Country of ref document: EP